Dossier: Parkinson's disease
Pesticides and Parkinson's disease

https://doi.org/10.1016/S0753-3322(99)80077-8Get rights and content

Summary

Epidemiological studies and case reports provide evidence for an association between Parkinson's disease and past exposure to pesticides. Susceptibility to the effects of pesticides and other putative neurotoxins depends on variability in xenobiotic metabolism possibly generated by genetic polymorphisms, aging and variation in exposure to environmental agents including pesticides. The simplest mechanistic hypothesis for the association of pesticides with Parkinson's disease is that pesticides or their metabolites are directly toxic to mitochondria, although modulation of xenobiotic metabolism by pesticides provides an adjunct or alternative hypothesis.

References (113)

  • DesoleMS et al.

    Effects of ageing on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxic effects on striatum and brainstem in the rat

    Neurosci Lett

    (1993)
  • Di IlioC et al.

    Interaction of glutathione transferase P1-1 with captan and captofol

    Biochem Pharmacol

    (1996)
  • DubeyRK et al.

    Effects of endosulfan and its metabolites on rat liver mitochondrial respiration and enzyme activities in vitro

    Biochem Pharmacol

    (1984)
  • DuvoisinRC

    A brief history of parkinsonism

    Neurol Clin

    (1992)
  • FerranteRJ et al.

    Systemic administration of rotenone produces selective damage in the striatum and globus pallidum, but not in the substantia nigra

    Brain Res

    (1997)
  • GolbeLI

    Parkinson's disease: nature meets nuture

    Lancet

    (1998)
  • HartTB

    Parkinson's disease and pesticides

    Lancet

    (1987)
  • JennerP

    Oxidative damage in neurodegenerative disease

    Lancet

    (1994)
  • KondoI et al.

    Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease

    Brain Res

    (1998)
  • McCannSJ et al.

    The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis

    J Neurol Sci

    (1997)
  • McNaughtKS et al.

    Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease

    Biochem Pharmacol

    (1998)
  • MenegonA et al.

    Parkinson's disease, pesticides and glutathione transferase polymorphisms

    Lancet

    (1998)
  • MorenoAJ et al.

    Mitochondrial bioenergetics as affected by DDT

    Biochim Biophys Acta

    (1991)
  • NicklasWJ et al.

    Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

    Life Sci

    (1985)
  • O'MalleyM

    Clinical evaluation of pesticide exposure and poisonings

    Lancet

    (1997)
  • PalmeiraCM et al.

    Interactions of herbicides 2,4-D and dinseb with liver mitochondrial bioenergetics

    Toxicol Appl Pharmacol

    (1994)
  • PalmeiraCM et al.

    Mitochondrial bioenergetics is affected by the herbicide, paraquat

    Biochim Biophys Acta

    (1995)
  • PoirierJ et al.

    Debrisoquine metabolism in parkinsonian patients treated with antihistamine drugs

    Lancet

    (1987)
  • SmithCA et al.

    Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease

    Lancet

    (1992)
  • BandmannO et al.

    Genetic aspects of Parkinson's disease

    Mov Disord

    (1998)
  • BarbeauA

    Etiology of Parkinson's disease: a research strategy

    Can J Neurol Sci

    (1984)
  • BarbeauA et al.

    Ecogenetics of Parkinson's disease: prevalence and environmental aspects in rural areas

    Can J Neurol Sci

    (1987)
  • BellIR et al.

    Psychological characteristics and subjective intolerance for xenobiotic agents of normal young adults and trait shyness and defensiveness

    J Nerv Ment Disord

    (1994)
  • BurnsRS et al.

    The clinical syndrome of striatal dopamine deficiency: parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

    N Engl J Med

    (1985)
  • BusJS et al.

    A mechanism of paraquat toxicity in mice and rats

    Toxicol Appl Pharmacol

    (1976)
  • ButlerAM et al.

    Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation

    J Pharmacol Exp Ther

    (1997)
  • ButterfieldPG et al.

    Environmental antecedents of young-onset Parkinson's disease

    Neurology

    (1993)
  • ChanDKY et al.

    Genetic and environmental risk factors for Parkinson's disease in a Chinese population

    J Neurol Neurosurg Psychiatry

    (1998)
  • ChapmanLJ et al.

    Finger tremor after carbon disulfide-based pesticide exposures

    Arch Neurol

    (1991)
  • CoccoP et al.

    Long-term health effects of the occupational exposure to DDT

    Ann NY Acad Sci

    (1997)
  • ColemanT et al.

    1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4 — implications for Parkinson's disease

    J Pharmacol Exp Ther

    (1996)
  • DavisKL et al.

    Single case study

    Possible organophosphate-induced parkinsonism

    J Nerv Ment Disord

    (1978)
  • DavisMW et al.

    Multidrug resistance associated protein, p-glycoprotein and Parkinson's disease

    Aust NZ J Med

    (1998)
  • EcobichonDJ et al.

    Pesticides and Neurological Diseases

    (1994)
  • EllenhornMJ et al.

    Ellenhorn's Medical Toxicology

    (1997)
  • FlemingL et al.

    Parkinson's disease and brain levels of organochlorine pesticides

    Ann Neurol

    (1994)
  • FurlongCE et al.

    Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism

    Neurotoxicology

    (1998)
  • GassnerB et al.

    The pyrethroids permethrin and cyhalothrin are potent inhibitors of the mitochondrial complex I

    J Pharmacol Exp Ther

    (1997)
  • GolbeLI et al.

    Follow-up study of early-life protective and risk factors in Parkinson's disease

    Mov Disord

    (1990)
  • GorellJM et al.

    The risk of Parkinson's disease with exposure to pesticides, farming, well water and rural living

    Neurology

    (1998)
  • Cited by (185)

    • Association between water and sanitation, air and emission pollution and climate change and neurological disease distribution: A study based on GBD data

      2021, Chemosphere
      Citation Excerpt :

      While increasing the quality of environmental variables, such as water and sanitation, is essential in national health policies (Bartram et al., 2005), increasing the quality of these variables, including drinking water through special processes such as coagulation and flocculation in water treatment, may lead to the emergence of undesired pollutants or an increase in the concentration of metals in water, which can have adverse effects on communities (WHO, 2003; Hazen, 2006; Bondy and Campbell, 2017; Dobaradaran et al., 2020). Previous studies have evaluated the association between NDs such as Alzheimer's and Parkinson's disease with water-related contaminants such as aluminum (a common coagulant used in water treatment plants in countries) (Martyn et al., 1989; Flaten, 1990, 2001; McLachlan et al., 1996; Gauthier et al., 2000; Rondeau et al., 2000; Shcherbatykh and Carpenter, 2007; Walton, 2014; Bondy, 2016; Nie, 2018; Van Dyke et al., 2020), pesticides, and the type of drinking water source (Jiménez-Jiménez et al., 1992; De Michele et al., 1996; Le Couteur et al., 1999; Betarbet et al., 2000; Petrovitch et al., 2002; Baldi et al., 2003; Ascherio et al., 2006; Gatto et al., 2009; Hristina et al., 2010; Das et al., 2011; Feldman et al., 2011; Pezzoli and Cereda, 2013) and the effects of trihalomethanes (Hazen, 2006; Wang et al., 2007; Basu et al., 2011; Garcia, 2011; Thokchom et al., 2020; Dobaradaran et al., 2020; Evlampidou et al., 2020) and bromates (Havelaar et al., 2000; USEPA, 2001; WHO, 2003; Ashbolt, 2004) on public health. For example, Rondeau et al. (2000) conducted a cohort study in France to investigate the effect of aluminum in drinking water on Alzheimer's disease and dementia and showed that the risk of Alzheimer's disease (adjusted relative risk = 2.14, 95% CI: 1.21–3.80) was significantly increased in people exposed to concentrations greater than 0.1 mg per liter (mg/L) (Rondeau et al., 2000).

    • Clinical Studies and Therapies in Parkinson’s Disease: Translations from Preclinical Models

      2021, Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models
    View all citing articles on Scopus
    View full text